| __timestamp | Lantheus Holdings, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 13673000 | 4101058 |
| Thursday, January 1, 2015 | 14358000 | 10763215 |
| Friday, January 1, 2016 | 12203000 | 5579049 |
| Sunday, January 1, 2017 | 18125000 | 32051299 |
| Monday, January 1, 2018 | 17071000 | 24482286 |
| Tuesday, January 1, 2019 | 20018000 | 43892589 |
| Wednesday, January 1, 2020 | 32788000 | 44505000 |
| Friday, January 1, 2021 | 44966000 | 79406000 |
| Saturday, January 1, 2022 | 311681000 | 49283000 |
| Sunday, January 1, 2023 | 77707000 | 17282730 |
Cracking the code
In the ever-evolving landscape of pharmaceuticals, innovation is the key to staying ahead. Lantheus Holdings, Inc. and Verona Pharma plc, two prominent players, have shown distinct approaches to research and development (R&D) over the past decade.
From 2014 to 2023, Lantheus Holdings, Inc. has consistently increased its R&D spending, peaking in 2022 with a remarkable 311% increase compared to 2014. This upward trend underscores their commitment to innovation, particularly in the field of diagnostic imaging.
Verona Pharma plc, on the other hand, experienced a significant surge in R&D investment in 2021, with a 93% increase from the previous year. This strategic boost highlights their focus on respiratory diseases, aiming to bring groundbreaking treatments to market.
Both companies exemplify the diverse strategies in the pharmaceutical industry, where innovation is not just a goal but a necessity.
Research and Development Investment: Zoetis Inc. vs Verona Pharma plc
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Research and Development Investment: Sarepta Therapeutics, Inc. vs Verona Pharma plc
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Verona Pharma plc and Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Verona Pharma plc and HUTCHMED (China) Limited
R&D Spending Showdown: Verona Pharma plc vs Dynavax Technologies Corporation
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.